NCT05133973View on ClinicalTrials.gov

Feasibility Study of a Transdermal Continuous Glucose Monitoring (CGM) System in Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

May 17, 2023

Conditions
Diabetes
Interventions
DEVICE

FiberSense CGM

FiberSense system, a novel CGM system, based on a fiber-optical sensor placed through the dermis of the patient.

Trial Locations (1)

89081

Institut für Diabetes-Technologie, Ulm

All Listed Sponsors
lead

EyeSense GmbH

INDUSTRY